Forcendra vs Haoxi Health Technology
FCDH and HAO side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FCDH and HAO compare
Haoxi Health Technology grew revenue faster over the last twelve months (67.1% versus −8.8% for Forcendra).
Haoxi Health Technology keeps more of each dollar of sales as profit, with a net margin of −17.4% compared with −114% at Forcendra.
Haoxi Health Technology scores higher on the StockData Score (4 against 2 for Forcendra), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FCDH | HAO |
|---|---|---|
| Size and price | ||
| Share price | $0.602 | $1.96 |
| Change, 1 year | −95.7% | −99.9% |
| Beta (5Y) | 2.55 | – |
| Employees | 42 | 30 |
| StockData Score | ||
| Total score | 2 | 4 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −8.8% | 67.1% (better) |
| Net income growth (TTM) | – | −346% |
| EPS growth (TTM) | – | −111% |
| Profitability | ||
| Gross margin | 23.7% (better) | 1.1% |
| Operating margin | −85.4% | −17.6% (better) |
| Net margin | −114% | −17.4% (better) |
| FCF margin | −46.9% | – |
| Return on equity | −318% | −54.1% (better) |
| Return on invested capital | −277% | −79.5% (better) |
| Financial health | ||
| Debt / equity | – | 0.09 |
| Interest coverage | −39.4× (better) | −184.3× |
| Current ratio | 1.47 | 4.53 (better) |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Years of dividend growth | 0 | – |
| Ownership | ||
| Held by institutions | 0.05% | – |
| Held by insiders | 0.00% | – |
| Insider net buying, 12 months | – | $800K |
Go deeper
- FCDH stock overview
- FCDH income statement
- FCDH valuation and score
- HAO stock overview
- HAO income statement
- HAO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.